# INNOVATE Corp.: filings

VATE · NYSE · CIK 1006837 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vate.md) · [Financials](/companies/vate/financials.md) · [Filings](/companies/vate/filings.md) · [Insiders](/companies/vate/insiders.md)

## Reports and events: 592 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 383, 4 312, SC 13D/A 75, DEFA14A 64, SC 13G/A 60, 3 56, 10-Q 53, SC 13G 27, DFAN14A 26, 425 25, 10-K 18, DEF 14A 18, UPLOAD 17, 8-K/A 16, CORRESP 16, 4/A 15, SC 13D 12, EFFECT 11, S-8 POS 10, 10-Q/A 8, 10-K/A 7, S-3 7, S-8 7, 424B5 6, PRE 14A 6, 8-A12B 5, S-3/A 5, 424B7 4, CERTNYS 3, NT 10-K 3, POS AM 3, 25 2, 8-A12G 2, CERT 2, D 2, DEF 14C 2, DEFC14A 2, NT 10-Q 2, PREC14A 2, 15-12B 1, 15-12B/A 1, 15-12G 1, 3/A 1, 424B2 1, 424B3 1, ARS 1, DEFM14A 1, DFRN14A 1, PRE 14C 1, PREM14A 1, PRER14A 1, PRRN14A 1, S-4 1, S-4/A 1, SCHEDULE 13D 1, SCHEDULE 13D/A 1, SCHEDULE 13G 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-09 | 20:15 ET | [8-K](/filings/0001006837-26-000121.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001006837-26-000121 |
| 2026-10-05 | 12:31 ET | [8-K](/filings/0001006837-26-000118.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001006837-26-000118 |
| 2026-09-02 | 20:18 ET | [8-K](/filings/0001006837-26-000110.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001006837-26-000110 |
| 2026-08-18 | 12:12 ET | [8-K](/filings/0001006837-26-000090.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001006837-26-000090 |
| 2026-08-14 | 20:37 ET | [SCHEDULE 13D](/filings/0001621020-26-000003.md) | Ownership report, active investor | 0001621020-26-000003 |
| 2026-08-10 | 12:26 ET | [8-K](/filings/0001006837-26-000076.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001006837-26-000076 |
| 2026-08-06 | 20:22 ET | [10-Q](/filings/0001006837-26-000063.md) | Quarterly report, period 2026-06-30 | 0001006837-26-000063 |
| 2026-08-06 | 20:13 ET | [8-K](/filings/0001006837-26-000061.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001006837-26-000061 |
| 2026-08-03 | 12:28 ET | [8-K](/filings/0001006837-26-000053.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001006837-26-000053 |
| 2026-07-08 | 20:14 ET | [8-K](/filings/0001006837-26-000051.md) | 8.01 Other events | 0001006837-26-000051 |
| 2026-06-11 | 20:35 ET | [8-K](/filings/0001006837-26-000048.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001006837-26-000048 |
| 2026-06-01 | 12:45 ET | [8-K](/filings/0001006837-26-000045.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001006837-26-000045 |
| 2026-05-14 | 20:13 ET | [10-Q](/filings/0001006837-26-000039.md) | Quarterly report, period 2026-03-31 | 0001006837-26-000039 |
| 2026-05-14 | 20:11 ET | [8-K](/filings/0001006837-26-000038.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001006837-26-000038 |
| 2026-04-28 | 20:32 ET | [DEF 14A](/filings/0001006837-26-000027.md) | Proxy statement, period 2025-12-31 | 0001006837-26-000027 |
| 2026-04-06 | 12:39 ET | [8-K](/filings/0001006837-26-000021.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001006837-26-000021 |
| 2026-03-31 | 13:00 ET | [8-K](/filings/0001006837-26-000019.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001006837-26-000019 |
| 2026-03-26 | 20:27 ET | [10-K](/filings/0001006837-26-000014.md) | Annual report, period 2025-12-31 | 0001006837-26-000014 |
| 2026-03-26 | 20:17 ET | [8-K](/filings/0001006837-26-000013.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001006837-26-000013 |
| 2026-02-10 | 21:08 ET | [8-K](/filings/0001006837-26-000005.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001006837-26-000005 |
| 2026-02-02 | 13:32 ET | [8-K](/filings/0001006837-26-000002.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001006837-26-000002 |
| 2025-12-16 | 13:07 ET | [8-K](/filings/0001006837-25-000134.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001006837-25-000134 |
| 2025-11-12 | 21:12 ET | [10-Q](/filings/0001006837-25-000127.md) | Quarterly report, period 2025-09-30 | 0001006837-25-000127 |
| 2025-11-12 | 21:08 ET | [8-K](/filings/0001006837-25-000126.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001006837-25-000126 |
| 2025-10-21 | 12:09 ET | [8-K](/filings/0001006837-25-000118.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001006837-25-000118 |
| 2025-10-16 | 21:22 ET | [8-K](/filings/0001006837-25-000115.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001006837-25-000115 |
| 2025-09-09 | 13:03 ET | [8-K](/filings/0001006837-25-000112.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001006837-25-000112 |
| 2025-08-05 | 20:18 ET | [10-Q](/filings/0001006837-25-000104.md) | Quarterly report, period 2025-06-30 | 0001006837-25-000104 |
| 2025-08-05 | 20:14 ET | [8-K](/filings/0001006837-25-000103.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001006837-25-000103 |
| 2025-08-05 | 00:22 ET | [8-K](/filings/0001006837-25-000097.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001006837-25-000097 |
| 2025-07-31 | 12:37 ET | [8-K](/filings/0001006837-25-000085.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001006837-25-000085 |
| 2025-07-28 | 20:20 ET | [8-K](/filings/0001006837-25-000081.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001006837-25-000081 |
| 2025-07-17 | 12:46 ET | [8-K](/filings/0001006837-25-000079.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001006837-25-000079 |
| 2025-06-12 | 20:20 ET | [8-K](/filings/0001006837-25-000060.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001006837-25-000060 |
| 2025-05-23 | 20:14 ET | [8-K](/filings/0001006837-25-000054.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001006837-25-000054 |
| 2025-05-21 | 20:16 ET | [8-K](/filings/0001006837-25-000050.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001006837-25-000050 |
| 2025-05-06 | 20:16 ET | [10-Q](/filings/0001006837-25-000045.md) | Quarterly report, period 2025-03-31 | 0001006837-25-000045 |
| 2025-05-06 | 20:09 ET | [8-K](/filings/0001006837-25-000044.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001006837-25-000044 |
| 2025-04-28 | 20:15 ET | [DEF 14A](/filings/0001006837-25-000033.md) | Proxy statement, period 2024-12-31 | 0001006837-25-000033 |
| 2025-03-31 | 20:08 ET | [10-K](/filings/0001006837-25-000021.md) | Annual report, period 2024-12-31 | 0001006837-25-000021 |
| 2025-03-31 | 20:06 ET | [8-K](/filings/0001006837-25-000020.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001006837-25-000020 |
| 2025-03-06 | 21:23 ET | [8-K](/filings/0001006837-25-000007.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001006837-25-000007 |
| 2025-02-25 | 14:03 ET | [8-K](/filings/0001006837-25-000005.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001006837-25-000005 |
| 2025-01-21 | 13:01 ET | [8-K](/filings/0001006837-25-000002.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001006837-25-000002 |
| 2024-12-18 | 21:32 ET | [SCHEDULE 13D/A](/filings/0001104659-24-129779.md) | Ownership report, active investor, amended | 0001104659-24-129779 |
| 2024-11-20 | 13:24 ET | [8-K](/filings/0001006837-24-000161.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001006837-24-000161 |
| 2024-11-06 | 21:07 ET | [10-Q](/filings/0001006837-24-000155.md) | Quarterly report, period 2024-09-30 | 0001006837-24-000155 |
| 2024-11-06 | 21:05 ET | [8-K](/filings/0001006837-24-000154.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001006837-24-000154 |
| 2024-09-03 | 21:14 ET | [8-K](/filings/0001006837-24-000129.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001006837-24-000129 |
| 2024-08-08 | 20:15 ET | [8-K](/filings/0001006837-24-000124.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001006837-24-000124 |

Page 1 of 12. [Older](/companies/vate/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.